News

Experience from Clinical Practice with Intestinal Gel LECIG in Treating Parkinson's Disease

12. 5. 2022 Source: Parkinson's Disease

A Swedish observational study evaluated the applicability of the LECIG intestinal gel, which contains levodopa (20 mg/ml), carbidopa (5 mg/ml), and entacapone (20 mg/ml), in clinical practice for patients with Parkinson's disease.

Eletriptan and Its Role in Acute Migraine Therapy

In the acute treatment of moderate to severe migraine attacks, medications from the triptan group are primarily used. The following article summarizes important findings about eletriptan and its key…

10. 5. 2022 Source: Treatment of Severe Migraine

Efficacy and Safety of Bimekizumab in the Treatment of Moderate to Severe Plaque Psoriasis -⁠ BE READY Study Results

The interleukin 17 (IL-17) family represents a group of pro-inflammatory cytokines that play a crucial role in the pathogenesis of psoriasis. Inhibiting interleukins from this family has a…

6. 5. 2022 Source: Psoriasis

Current View on the Issue of Protein Intake in Critically Ill Patients

A summary of current knowledge and guidelines concerning the nutritional needs of critically ill patients presented last year in the journal Clinical Nutrition deals with protein intake, specifically…

5. 5. 2022 Source: Parenteral Nutrition

Reduction of Mortality in Patients After Abdominal Surgery in Critical Condition Thanks to Early Supplemental Parenteral Nutrition

Ensuring adequate nutrition is an important part of therapy for critically ill patients to achieve better clinical outcomes in terms of both survival and recovery speed. The preferred option is…

5. 5. 2022 Source: Parenteral Nutrition

Empagliflozin Secures Reimbursement for Heart Failure Treatment

Starting May 1st, health insurance companies will cover Jardiance^® (empagliflozin) for patients with heart failure with reduced ejection fraction. Cardiologists, pediatric cardiologists,…

3. 5. 2022 Source: Heart Failure

Gut-Brain Axis −⁠ Future of MS Treatment?

The relationship between the gut microbiome and multiple sclerosis has been a major topic recently. How far has current science progressed in decoding this issue? A recent review article published in…

3. 5. 2022 Source: Multiple Sclerosis

Teriflunomide under the microscope in studies and practice

Not always do the conclusions from clinical studies fully confirm in real clinical practice. Does this also apply to teriflunomide? Is its efficacy and safety consistent across age groups and…

3. 5. 2022 Source: Multiple Sclerosis

Is it possible to extend the life of diabetics thanks to modern treatment?

People aged 60 with type 2 diabetes are estimated to live on average 6-7 years less compared to their peers without a diabetes diagnosis. However, clinical study results suggest that modern therapy…

29. 4. 2022 Source: Diabetes

Extract from Aloe barbadensis in the Treatment of Irritable Bowel Syndrome

The authors of a pooled analysis of two randomized controlled trials evaluated whether administration of Aloe barbadensis extract in patients with diarrhea-predominant irritable bowel syndrome (IBS)…

29. 4. 2022 Source: Irritable Bowel Syndrome

Updated Recommendations for Treatment of von Willebrand Disease

In 2021, new recommendations for the therapy of von Willebrand disease (vWD) were published, based on a consensus by the American Society of Hematology (ASH), the International Society on Thrombosis…

28. 4. 2022 Source: Von Willebrand Disease

srdeční selhání se zachovalou ejekční frakcí

Efficacy and Safety of Empagliflozin in Patients with Heart Failure with Preserved Ejection Fraction

Previous studies have shown that the antidiabetic drug empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure with reduced left…

27. 4. 2022 Source: Heart Failure

Brentuximab Vedotin in Patients with R/R cHL in the Real World: What to Expect?

How does brentuximab vedotin (BV) perform as maintenance therapy in real-world practice for patients with relapsed or refractory classical Hodgkin lymphoma (R/R cHL) who have undergone autologous…

27. 4. 2022 Source: Hematologic Malignancies

What Response to the COVID-19 Vaccine Can Be Expected in Patients After Stem Cell Transplantation?

During the recent virtual congress of the European Society for Blood and Marrow Transplantation (EBMT 2022), a study by Saudi experts was presented that explored the response to vaccination against…

27. 4. 2022 Source: Hematologic Malignancies

News in the Treatment of Allergic Rhinitis

According to literary sources, 17–28.5% of Europeans suffer from allergic rhinitis (AR), which negatively affects the quality of daily life. Below, we summarize the new recommendations from ARIA…

27. 4. 2022 Source: Life Without Allergic Rhinitis

1 … 53 54 55 56 57 … 115

Back Filter by speciality

Remove filters